The indications and operative results of hepatic resections were investigated in 100 consecutive patients over the past 20 years. There were 61 hepatocellular carcinoma, 13 hepatolithiasis, and 26 other miscellaneous diseases. An overall hospital mortality rate was 25%. It was 26, 0, and 35% in patients with hepatocellular carcinoma, hepatolithiasis, and other diseases, respectively. There was not any significant difference between survived and deceased cases in their preoperative laboratory data. The volume of operative blood loss in deceased cases was significantly larger than that in survived cases, so the influence of operative blood loss on morbidity and mortality was investigated. The incidences of postoperative bleeding, hepatic insufficiency, pulmonary insufficiency, and hospital death were significantl) higher in patients whose operative blood loss exceeded 5000 ml. These results indicate that operative blood loss is one of the critical factors that decide the operative prognosis.
H EPATIC RESECTION is a major operation that' many surgeons have challenged for this century, and a great deal of knowledge has been accumulated with technical improvement. It has become a much safer operation than ever before. Recent advances in diagnosis, including alpha-fetoprotein, ultrasonography, and computed tomography, have increased the chances of detecting hepatic tumors. The therapeutic value of hepatic resection has become more important in the clinical field. However, hepatic resection is still confined to a few major medical centers; its operative risk is still higher than other surgical procedures. Especially in Japan, the major indication for hepatic resection is hepatocellular carcinoma, and the incidence of concomitant cirrhosis is much higher than in the West.' Resecting the cirrhotic liver encounters several difficult problems. Its poor functional reserve and technical difficulty have interfered with the improvement of operative results.
Our department is one of the major centers of hepatic surgery in ~a~a n .
We have performed more than 100
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hepatic resections over the past 20 years. In this study, clinical charts of 100 consecutive patients who had undergone therapeutic hepatic resections in our department were surveyed. Indications, preoperative laboratory data, operative procedures, postoperative complications, and mortality were investigated. The purpose of this paper is to summarize our experience in hepatic surgery, and to make clear the problems remaining in the future.
Patients and Methods
One hundred Japanese patients underwent therapeutic hepatic resections from January 1963 to June 1983 at the First Surgical Department, Tokyo University Hospital, Tokyo, Japan. Clinical charts of these patients were reviewed, focusing on the indications, preoperative evaluation, operative procedures, and short-term prognosis.
Indications
Hepatic diseases, for which resections were performed, were classified into groups of hepatocellular carcinoma, hepatolithiasis, and other miscellaneous diseases. The number of patients with other diseases was not large, so these patients were summarized in one group.
In order to perform hepatic resection safely, evaluation of hepatic functional reserve is very important, as well as the exact diagnosis of localization of the lesion. This is especially true in our country, where predominant indication for hepatic resection is hepatocellular carcinoma with cirrhosis. Although nearly 80% of normal hepatic tissue can be removed safely, the resectable volume reduces according to the severity of cirrhosis. Formerly, experienced surgeons evaluated the severity of cirrhosis, hepatic functional reserve, from the results
